Entity Common Stock, Shares Outstanding of AVADEL PHARMACEUTICALS PLC from Q4 2011 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
AVADEL PHARMACEUTICALS PLC quarterly Entity Common Stock, Shares Outstanding history and change rate from Q4 2011 to Q3 2025.
  • AVADEL PHARMACEUTICALS PLC Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 97,656,664, a 1.3% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 97,656,664 +1,295,136 +1.3% 31 Oct 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 97,097,639 +827,111 +0.86% 05 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 96,629,435 +513,112 +0.53% 26 Feb 2025 10-K 03 Mar 2025 2024 FY
Q3 2024 96,361,528 +6,555,875 +7.3% 08 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 96,270,528 +6,902,553 +7.7% 05 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 96,116,323 +31,638,815 +49% 24 Apr 2024 10-K/A 26 Apr 2024 2023 FY
Q3 2023 89,805,653 +28,026,921 +45% 06 Nov 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 89,367,975 +29,574,604 +49% 04 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 64,477,508 +5,445,271 +9.2% 23 Mar 2023 10-K 29 Mar 2023 2022 FY
Q3 2022 61,778,732 +3,158,644 +5.4% 07 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 59,793,371 +1,197,133 +2% 04 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 59,032,237 +567,086 +0.97% 11 Mar 2022 10-K 16 Mar 2022 2021 FY
Q3 2021 58,620,088 +347,354 +0.6% 04 Nov 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 58,596,238 +375,604 +0.64% 05 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 58,465,151 +12,060,719 +26% 04 Mar 2021 10-K 09 Mar 2021 2020 FY
Q3 2020 58,272,734 +20,822,434 +56% 05 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 58,220,634 +20,770,334 +55% 06 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 46,404,432 +9,048,921 +24% 10 Mar 2020 10-K 16 Mar 2020 2019 FY
Q3 2019 37,450,300 +438,286 +1.2% 08 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 37,450,300 +685,736 +1.9% 06 Aug 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 37,355,511 -596,608 -1.6% 13 Mar 2019 10-K 15 Mar 2019 2018 FY
Q3 2018 37,012,014 -2,750,195 -6.9% 02 Nov 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 36,764,564 -3,319,594 -8.3% 02 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 37,952,119 -3,427,435 -8.3% 09 Mar 2018 10-K 16 Mar 2018 2017 FY
Q3 2017 39,762,209 -1,479,045 -3.6% 02 Nov 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 40,084,158 -1,157,096 -2.8% 02 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 41,379,554 +138,300 +0.34% 20 Mar 2017 10-K 28 Mar 2017 2016 FY
Q3 2016 41,241,254 07 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 41,241,254 +742,490 +1.8% 03 Aug 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 41,241,254 +988,240 +2.5% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q2 2015 40,498,764 +1,917,464 +5% 30 Jun 2015 6-K 31 Dec 2015 2015 Q2
Q1 2015 40,253,014 +1,985,464 +5.2% 31 Mar 2015 6-K 10 Jul 2015 2015 Q1
Q4 2014 40,191,264 +14,578,714 +57% 31 Dec 2014 20-F 01 Oct 2015 2014 FY
Q3 2014 38,936,300 +38,936,300 30 Sep 2014 6-K 17 Nov 2014 2014 Q3
Q2 2014 38,581,300 +13,115,900 +52% 30 Jun 2014 6-K 08 Aug 2014 2014 Q2
Q1 2014 38,267,550 31 Mar 2014 6-K 08 Jul 2014 2014 Q1
Q4 2013 25,612,550 +650,300 +2.6% 31 Dec 2013 20-F/A 30 Apr 2014 2013 FY
Q3 2013 0 30 Sep 2013 6-K 15 Jan 2014 2013 Q3
Q2 2013 25,465,400 +308,150 +1.2% 30 Jun 2013 6-K 06 Dec 2013 2013 Q2
Q4 2012 24,962,250 0 0% 31 Dec 2012 20-F 30 Apr 2013 2012 FY
Q2 2012 25,157,250 30 Jun 2012 6-K 14 Dec 2012 2012 Q2
Q1 2012 25,157,250 31 Mar 2012 6-K 13 Sep 2012 2012 Q1
Q4 2011 24,962,250 31 Dec 2011 20-F 27 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.